Skip to main content
. 2021 Apr 12;95(9):e01394-19. doi: 10.1128/JVI.01394-19

TABLE 2.

Reports of adverse effects of select live-attenuated RVFV vaccines in pregnant livestocka

Vaccine Gestation period Dose and/or delivery route No. of pregnant animals with spontaneous abortions/total no. of animals vaccinated (%) Effect(s) on fetuses Description Reference(s)
Smithburn or MLVV Not reported s.c. Cattle, 28/100 (28) Early fetal death and mummification Animals received multiple doses of formalin-inactivated vaccine prior to vaccination with Smithburn 26
Various (from both experimental and field vaccinations) s.c., i.v., or i.d. Sheep, 386/1,150 (44) Stillbirths, teratogenesis, viremia Hydranencephaly, hypoplasia (cerebrum, cerebellum, spinal), brachygnathia, arthrogryposis, scoliosis, hydrops amnii 27
Clone 13 Early gestation 1 × 105 PFU s.c. Cattle, 0/17 (0) None reported 30
Sheep, 0/17 (0)
Goats, 0/12 (0)
Late gestation 1 × 105 PFU s.c. Cattle, 0/8 (0) None reported 31
Sheep, 0/30 (0)
Goats, 0/36 (0)
Late gestation (120 days) 6.8 log10 TCID50/ml s.c. or i.d. Sheep, 0/12 (0) 0/28 teratogenicity 32
4/28 (14%) viremic
MP-12 Early gestation (28–56 days) 1 × 106 PFU s.c. Sheep, 2/50 (4) 15–23% teratogenic effects in delivered lambs Hydranencephaly, hypoplasia (cerebellum, spinal), prognathia inferior, brachygnathia, arthrogryposis, scoliosis, lordosis, kyphosis, domed head 41
Late gestation (90–110 days) 5 × 103 PFU s.c. Sheep (0) None reported NA 39, 82
Early/midgestation (90 or 150 days) 1 × 105 PFU s.c. to pregnant sow or i.m. directly to fetus Cattle (0) None reported NA 38, 40
ΔNSsΔNSm Early (42 days) 1 × 104 PFU s.c. 0/29 (0) None reported No RVFV vRNA found in lamb tissues 83
a

MLVV, modified live virus vaccine; s.c., subcutaneous; i.m., intramuscular; i.d., intradermal; i.v., intravenous; TCID50, 50% tissue culture infective dose; vRNA, viral RNA; NA, not applicable.